These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 13680279
1. Absence of prostate apoptosis response-4 protein in substantia nigra of Parkinson's disease autopsies. Moos T, Jensen PH. Acta Neuropathol; 2004 Jan; 107(1):23-6. PubMed ID: 13680279 [Abstract] [Full Text] [Related]
2. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease. Duan W, Zhang Z, Gash DM, Mattson MP. Ann Neurol; 1999 Oct; 46(4):587-97. PubMed ID: 10514095 [Abstract] [Full Text] [Related]
3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L, Garris BL, Garris DR, Lau YS. Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572 [Abstract] [Full Text] [Related]
4. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons. Hill WD, Arai M, Cohen JA, Trojanowski JQ. J Comp Neurol; 1993 Mar 15; 329(3):328-36. PubMed ID: 8459049 [Abstract] [Full Text] [Related]
5. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Allen AM, MacGregor DP, Chai SY, Donnan GA, Kaczmarczyk S, Richardson K, Kalnins R, Ireton J, Mendelsohn FA. Ann Neurol; 1992 Sep 15; 32(3):339-44. PubMed ID: 1416803 [Abstract] [Full Text] [Related]
6. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. Patt S, Gertz HJ, Gerhard L, Cervós-Navarro J. Histol Histopathol; 1991 Jul 15; 6(3):373-80. PubMed ID: 1725760 [Abstract] [Full Text] [Related]
7. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA. Exp Neurol; 2000 Nov 15; 166(1):127-35. PubMed ID: 11031089 [Abstract] [Full Text] [Related]
8. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y. Histol Histopathol; 1997 Jan 15; 12(1):25-31. PubMed ID: 9046040 [Abstract] [Full Text] [Related]
9. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Mogi M, Kondo T, Mizuno Y, Nagatsu T. Neurosci Lett; 2007 Feb 27; 414(1):94-7. PubMed ID: 17196747 [Abstract] [Full Text] [Related]
10. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Wang YQ, Bian GL, Bai Y, Cao R, Chen LW. Neurochem Int; 2008 Sep 27; 53(3-4):56-62. PubMed ID: 18639597 [Abstract] [Full Text] [Related]
11. Akt signal transduction dysfunction in Parkinson's disease. Timmons S, Coakley MF, Moloney AM, O' Neill C. Neurosci Lett; 2009 Dec 18; 467(1):30-5. PubMed ID: 19800394 [Abstract] [Full Text] [Related]
12. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL. Brain; 2005 Nov 18; 128(Pt 11):2654-64. PubMed ID: 16000336 [Abstract] [Full Text] [Related]
13. An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Anichtchik OV, Rinne JO, Kalimo H, Panula P. Exp Neurol; 2000 May 18; 163(1):20-30. PubMed ID: 10785440 [Abstract] [Full Text] [Related]
14. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H. J Neurochem; 2004 Oct 18; 91(2):451-61. PubMed ID: 15447678 [Abstract] [Full Text] [Related]
15. Detrimental deletions: mitochondria, aging and Parkinson's disease. Biskup S, Moore DJ. Bioessays; 2006 Oct 18; 28(10):963-7. PubMed ID: 16998822 [Abstract] [Full Text] [Related]
16. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits. Zhang J, Stanton DM, Nguyen XV, Liu M, Zhang Z, Gash D, Bing G. Neuroscience; 2005 Oct 18; 135(3):829-38. PubMed ID: 16165292 [Abstract] [Full Text] [Related]
17. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A. Neuroreport; 2006 Jul 31; 17(11):1215-8. PubMed ID: 16837857 [Abstract] [Full Text] [Related]
18. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Mueller HT, Haroutunian V, Davis KL, Meador-Woodruff JH. Brain Res Mol Brain Res; 2004 Feb 05; 121(1-2):60-9. PubMed ID: 14969737 [Abstract] [Full Text] [Related]
19. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Goto S, Hirano A, Matsumoto S. Ann Neurol; 1989 Dec 05; 26(6):766-70. PubMed ID: 2557795 [Abstract] [Full Text] [Related]
20. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB. Ann N Y Acad Sci; 2005 Aug 05; 1053():356-75. PubMed ID: 16179542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]